Efficacy of risankizumab after intra-class switching between anti IL-23 antagonists: a multi-center, retrospective, real-life observation
- PMID: 37997317
- DOI: 10.23736/S2784-8671.23.07648-X
Efficacy of risankizumab after intra-class switching between anti IL-23 antagonists: a multi-center, retrospective, real-life observation
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical